Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $118.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.86 | 3.43% Avg Daily Range (30 D): $0.05 | 3.40% Avg Daily Range (90 D): $0.05 | 3.55% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 184 Avg Trade Size (Sh.) (90 D): 187 Institutional Trades Total Inst.Trades: 1,917 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $1.51M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 121.31K     News Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Aug 7, 2025 @ 12:28 AM Zentalis (ZNTL) Q2 Loss Narrows 70% Source: Jesterai Jul 1, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Jun 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.37 $-.67 $-.66 Diluted EPS $-.37 $-.67 $-.66 Revenue $ M $ M $ 26.87M Gross Profit $ $ $ Net Income / Loss $ -26.87M $ -48.28M $ -47.47M Operating Income / Loss $ -36.06M $ -45.62M $ -49.85M Cost of Revenue $ $ $ Net Cash Flow $ -4.33M $ 8.03M $ -7.42M PE Ratio